Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Dependovirus Medicine & Life Sciences
Genes Medicine & Life Sciences
Genetic Therapy Medicine & Life Sciences
Capsid Medicine & Life Sciences
Genome Medicine & Life Sciences
DNA Medicine & Life Sciences
Transgenes Medicine & Life Sciences
Gene Expression Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1993 2018

Congenital Structural Myopathies
Genetic Therapy
Canidae
Respiratory Muscles
Muscle Weakness
Blindness
Glycosaminoglycans
Genetic Therapy
Bone Marrow
Iduronidase

Research Output 1980 2016

19 Citations
Dependovirus
HEK293 Cells
Transfection
Culture Media
Suspensions
18 Citations

Adeno-associated virus as a mammalian DNA vector

Salganik, M., Hirsch, M. L. & Samulski, R. J. 2015 In : Microbiology Spectrum. 3, 4, MDNA3-0052-2014

Research output: Research - peer-reviewArticle

Dependovirus
DNA
virus
Tropism
Capsid
50 Citations

Adeno-Associated Virus at 50: A Golden Anniversary of Discovery, Research, and Gene Therapy Success - A Personal Perspective

Hastie, E. & Samulski, R. J. May 1 2015 In : Human Gene Therapy. 26, 5, p. 257-265 9 p.

Research output: Research - peer-reviewReview article

Dependovirus
Anniversaries and Special Events
Genetic Therapy
Research
Genetic Association Studies
8 Citations

Adeno-associated virus vector mediated delivery of the HBV genome induces chronic hepatitis B virus infection and liver fibrosis in mice

Ye, L., Yu, H., Li, C., Hirsch, M. L., Zhang, L., Samulski, R. J., Li, W. & Liu, Z. Jun 15 2015 In : PLoS One. 10, 6, e0130052

Research output: Research - peer-reviewArticle

Dependovirus
chronic hepatitis B
liver cirrhosis
Hepatitis B virus
genome

Breakthroughs and barriers in clinical gene therapy

Liang, K. J., Gaylor, J. P. & Samulski, R. J. Oct 1 2015 Advances and challenges in the Delivery of Nucleic Acid Therapeutics. Future Medicine Ltd., Vol. 1, p. 21-47 27 p.

Research output: ResearchChapter